Gopalan Vasundara, Deshpande Swati G, Zade Anup A, Tote Darshana, Rajendran Rahul, Durge Shubham, Bhargava Abhilasha
General Surgery, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus. 2024 Aug 5;16(8):e66186. doi: 10.7759/cureus.66186. eCollection 2024 Aug.
Follicular thyroid carcinoma (FTC) is the second most common type of thyroid cancer, presenting unique diagnostic and therapeutic challenges. This review provides a comprehensive analysis of the recent advancements in the diagnosis and treatment of FTC, emphasizing the significance of these developments in improving patient outcomes. We discuss the evolution of diagnostic techniques, including advancements in imaging modalities, fine needle aspiration biopsy, and molecular diagnostics, which have enhanced the accuracy of FTC detection and differentiation from benign conditions. The review also evaluates current treatment strategies, including surgical interventions, radioactive iodine therapy, and targeted therapies, examining their effectiveness and impact on patient prognosis. Additionally, we address ongoing challenges in FTC management, such as variability in treatment guidelines and disparities in care. Finally, the review explores emerging therapies and future research directions, highlighting innovations that may further optimize FTC management. By synthesizing current knowledge and identifying future research opportunities, this review aims to contribute to refining diagnostic and therapeutic approaches for FTC.
滤泡性甲状腺癌(FTC)是第二常见的甲状腺癌类型,带来了独特的诊断和治疗挑战。本综述全面分析了FTC诊断和治疗的最新进展,强调了这些进展对改善患者预后的重要性。我们讨论了诊断技术的演变,包括成像方式、细针穿刺活检和分子诊断的进展,这些进展提高了FTC检测的准确性以及与良性疾病的鉴别能力。该综述还评估了当前的治疗策略,包括手术干预、放射性碘治疗和靶向治疗,审视了它们的有效性及其对患者预后的影响。此外,我们探讨了FTC管理中持续存在的挑战,如治疗指南的差异和护理差距。最后,该综述探索了新兴疗法和未来研究方向,突出了可能进一步优化FTC管理的创新。通过综合当前知识并确定未来研究机会,本综述旨在为完善FTC的诊断和治疗方法做出贡献。